Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06953141 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ultrasound for Assessment of Intra-Abdominal Blood Loss After Gynecological Surgery

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: May 10, 2026 to Nov 10, 2026
    • Study completion date: Jul 15, 2026 to Dec 15, 2026
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 10, 2025 to May 8, 2025
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective cohort study designed to assess intra-abdominal blood volume and hemodynamic status by measuring the diameter of the inferior vena cava (IVC) using 3D and Doppler ultrasound within 24 hours after gynecological surgery. The study will examine the association between these ultrasound findings and postoperative outcomes, including hemoglobin drop, need for blood transfusion, pain, infection, and length of hospitalization. Approximately 250 women undergoing laparotomy, laparoscopy, or vaginal surgery at Holy Family Hospital will be enrolled. The study also aimed to define postoperative normograms for fluid volume and IVC parameters and to evaluate whether ultrasound-guided decision-making could improve postoperative care and reduce unnecessary interventions.
Trial Details
NCT Number NCT06953141
Lead Sponsor Holy Family Hospital, Nazareth, Israel
Conditions
(from sponsor)		 Post-Operative Hematoma at Operative Site (Diagnosis), Post-Operative Hemorrhage
Related terms Disease, Postoperative Hemorrhage
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov